Impact of Phosphorus Restriction and Vitamin D-Substitution on Secondary Hyperparathyroidism in a Proteinuric Mouse Model

Publisher： Karger

E-ISSN： 1423-0143|40|2|153-165

ISSN： 1420-4096

Source： Kidney and Blood Pressure Research, Vol.40, Iss.2, 2015-03, pp. : 153-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vitamin D Analogs for the Treatment of Secondary Hyperparathyroidism

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite

Analysis of α-Klotho, Fibroblast Growth Factor-, Vitamin-D and Calcium-Sensing Receptor in 70 Patients with Secondary Hyperparathyroidism

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 1, 2013-03 ,pp. : 84-94

Karger

Access to resources Recommend Favorite

Treatment of Secondary Hyperparathyroidism in Hemodialyzed Patients with High-Dose Calcium Carbonate without Vitamin D3 Supplements

By  

American Journal of Nephrology, Vol. 19, Iss. 3, 1999-06 ,pp. : 428-432

Karger

Access to resources Recommend Favorite

Yet Another Vitamin D Analogue for the Management of Secondary Hyperparathyroidism: A Triton among the Minnows?

By  

American Journal of Nephrology, Vol. 43, Iss. 3, 2016-04 ,pp. : 221-224

Karger

Access to resources Recommend Favorite

Management of Secondary Hyperparathyroidism: The Importance and the Challenge of Controlling Parathyroid Hormone Levels without Elevating Calcium, Phosphorus, and Calcium-Phosphorus Product

By  

American Journal of Nephrology, Vol. 23, Iss. 6, 2003-11 ,pp. : 369-379

Karger

Access to resources Recommend Favorite